Effect of Intranasal DDAVP in Prevention of Hypotension during Hemodialysis
Efecto de la DDVAP intranasal en la prevención de la hipotensión durante la hemodiálisis
Read
9297
Timeswas read the article
2497
Total PDF
6800
Total HTML
Share statistics
array:21 [ "pii" => "X2013251412000503" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Nov.10967" "estado" => "S300" "fechaPublicacion" => "2012-01-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:89-93" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5196 "formatos" => array:3 [ "EPUB" => 311 "HTML" => 4160 "PDF" => 725 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699512000506" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Nov.10967" "estado" => "S300" "fechaPublicacion" => "2012-01-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:89-93" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7932 "formatos" => array:3 [ "EPUB" => 299 "HTML" => 6736 "PDF" => 897 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Efecto de la DDVAP intranasal en la prevención de la hipotensión durante la hemodiálisis" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "89" "paginaFinal" => "93" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Effect of Intranasal DDAVP in Prevention of Hypotension during Hemodialysis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Seyed S. Beladi-Mousavi, Marzieh Beladi-Mousavi, Fatemeh Hayati, Mehdi Talebzadeh" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Seyed S." "apellidos" => "Beladi-Mousavi" ] 1 => array:2 [ "nombre" => "Marzieh" "apellidos" => "Beladi-Mousavi" ] 2 => array:2 [ "nombre" => "Fatemeh" "apellidos" => "Hayati" ] 3 => array:2 [ "nombre" => "Mehdi" "apellidos" => "Talebzadeh" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251412000503" "doi" => "10.3265/Nefrologia.pre2011.Nov.10967" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000503?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000506?idApp=UINPBA000064" "url" => "/02116995/0000003200000001/v0_201502091357/X0211699512000506/v0_201502091357/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251412000499" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Nov.10867" "estado" => "S300" "fechaPublicacion" => "2012-01-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:94-102" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6814 "formatos" => array:3 [ "EPUB" => 320 "HTML" => 5614 "PDF" => 880 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Echocardiographic impact of hydration status in dialysis patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "94" "paginaFinal" => "102" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Repercusión ecocardiográfica del estado de hidratación en los pacientes en diálisis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10867_16025_25587_en_t1_10867i2.jpg" "Alto" => 1464 "Ancho" => 2126 "Tamanyo" => 857195 ] ] "descripcion" => array:1 [ "en" => "Characteristics of patients on peritoneal haemodialysis and dialysis" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Isabel Juan García, Isabel Juan-García, María Jesús Puchades, María J. Puchades, Rafael Sanjuan, Rafael Sanjuán, Isidro Torregrosa, Miguel Angel Solis, Miguel Á. Solís, Marisa Blasco, Miguel González, Antonio Martinez, Alfonso Miguel, Antonio Martínez" "autores" => array:16 [ 0 => array:2 [ "nombre" => "Isabel" "apellidos" => "Juan García" ] 1 => array:2 [ "nombre" => "Isabel" "apellidos" => "Juan-García" ] 2 => array:2 [ "nombre" => "María Jesús" "apellidos" => "Puchades" ] 3 => array:2 [ "nombre" => "María J." "apellidos" => "Puchades" ] 4 => array:2 [ "nombre" => "Rafael" "apellidos" => "Sanjuan" ] 5 => array:2 [ "nombre" => "Rafael" "apellidos" => "Sanjuán" ] 6 => array:2 [ "nombre" => "Isidro" "apellidos" => "Torregrosa" ] 7 => array:2 [ "nombre" => "Miguel Angel" "apellidos" => "Solis" ] 8 => array:2 [ "nombre" => "Miguel Á." "apellidos" => "Solís" ] 9 => array:2 [ "nombre" => "Marisa" "apellidos" => "Blasco" ] 10 => array:2 [ "nombre" => "Miguel" "apellidos" => "González" ] 11 => array:2 [ "nombre" => "Antonio" "apellidos" => "Martinez" ] 12 => array:2 [ "nombre" => "Marisa" "apellidos" => "Blasco" ] 13 => array:2 [ "nombre" => "Alfonso" "apellidos" => "Miguel" ] 14 => array:2 [ "nombre" => "Antonio" "apellidos" => "Martínez" ] 15 => array:2 [ "nombre" => "Alfonso" "apellidos" => "Miguel" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699512000491" "doi" => "10.3265/Nefrologia.pre2011.Nov.10867" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000491?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000499?idApp=UINPBA000064" "url" => "/20132514/0000003200000001/v0_201502091620/X2013251412000499/v0_201502091620/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251412000511" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Nov.11110" "estado" => "S300" "fechaPublicacion" => "2012-01-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:79-88" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6037 "formatos" => array:3 [ "EPUB" => 335 "HTML" => 5009 "PDF" => 693 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "The lack of income is associated with reduced survival in chronic haemodialysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "79" "paginaFinal" => "88" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La falta de ingresos económicos se asocia a menor supervivencia en hemodiálisis crónica" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11110_16025_24890_en_t111110i.jpg" "Alto" => 1637 "Ancho" => 900 "Tamanyo" => 526114 ] ] "descripcion" => array:1 [ "en" => "Basic patient characteristics" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sergio Marinovich, Carlos Lavorato, Guillermo Rosa-Diez, Liliana Bisigniano, Víctor Fernández, Daniela Hansen-Krogh" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Sergio" "apellidos" => "Marinovich" ] 1 => array:2 [ "nombre" => "Carlos" "apellidos" => "Lavorato" ] 2 => array:2 [ "nombre" => "Guillermo" "apellidos" => "Rosa-Diez" ] 3 => array:2 [ "nombre" => "Liliana" "apellidos" => "Bisigniano" ] 4 => array:2 [ "nombre" => "Víctor" "apellidos" => "Fernández" ] 5 => array:2 [ "nombre" => "Daniela" "apellidos" => "Hansen-Krogh" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699512000514" "doi" => "10.3265/Nefrologia.pre2011.Nov.11110" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000514?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000511?idApp=UINPBA000064" "url" => "/20132514/0000003200000001/v0_201502091620/X2013251412000511/v0_201502091620/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "titulo" => "Effect of Intranasal DDAVP in Prevention of Hypotension during Hemodialysis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "89" "paginaFinal" => "93" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Seyed S. Beladi-Mousavi, Marzieh Beladi-Mousavi, Fatemeh Hayati, Mehdi Talebzadeh" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Seyed S." "apellidos" => "Beladi-Mousavi" "email" => array:1 [ 0 => "beladimusavi@yahoo.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Marzieh" "apellidos" => "Beladi-Mousavi" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Fatemeh" "apellidos" => "Hayati" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "nombre" => "Mehdi" "apellidos" => "Talebzadeh" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of internal medicine, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Science and Research Branch, Department of Chemistry, Islamic Azad University, Omidiyeh, Iran, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efecto de la DDVAP intranasal en la prevención de la hipotensión durante la hemodiálisis" ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">Although considerable technical improvements have gained since the introduction of hemodialysis in the early 1950’s and life expectancy of patients with End stage renal disease (ESRD) has improved, there are some complications with different underlying mechanisms that commonly occur during hemodialysis (HD) including intradialytic hypotension (IDH), Cramps, Itching, Nausea and vomiting, Chest and Back pain, Headache, and Fever and chills<span class="elsevierStyleSup">1-4</span>.<span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara">IDH is an important side effect of HD and continues to be a leading problem, especially in the elderly and cardiovascularly compromised patients and it has a negative impact on health-related quality of life<span class="elsevierStyleSup">5-7</span>. In some patients, the development of IDH necessitates decrease of the blood flow rate in HD apparatus and in some times, even discontinuation of HD and therefore it is an important cause of under dialysis. On the other hand, in the patients that they are need to ultrafiltration during HD, the development of hypotention episodes contribute to discontinuation of ultrafiltration and in some times, even necessitate intravenous fluid replacement before they are able to leave the dialysis unit and therefore, this problem can cause volume overload and some other significant complication<span class="elsevierStyleSup">7</span>.</p><p class="elsevierStylePara">Unfortunately the incidence of this problem is very high especially among patients that they are received ultrafiltration during dialysis. It is occurred in significant percent of ESRD patients during or immediately following HD and its incidence ranges from 15 to 50 percent of dialysis sessions<span class="elsevierStyleSup">7,8</span>.</p><p class="elsevierStylePara">Although a number of Studies have been evaluated to decrease the incidence of IDH, however because of small number of comparative studies and conflicting results, there are no generally accepted guidelines for prevention of hypotension during hemodialysis<span class="elsevierStyleSup">9-14</span>.</p><p class="elsevierStylePara">The aim of this study is evaluating the possible effect of intranasal DDAVP for prevention of IDH episodes during hemodialysis</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">MATERIAL AND METHODS</span></p><p class="elsevierStylePara">In a cross sectional clinical trial from May 2010 to September 2010, the present double blinded study was performed on ESRD patients who underwent hemodialysis treatments at Imam hospital, Ahvaz, Iran.<span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara">The ESRD was defined as permanent and irreversible loss of renal function due to any causes with creatinine clearance of less than 10-15 ml/min per 1.73m<span class="elsevierStyleSup">2 </span>requiring renal replacement therapy.</p><p class="elsevierStylePara">A standardized questionnaire was used to collect general information such as age, gender, the record of previous diseases and drugs, vital signs, causes of ESRD, date of onset of HD and length of time receiving HD services.</p><p class="elsevierStylePara">HD patients with known symptomatic episode of IDH in at least 30% of HD session in the 30 days preceding enrollment were included and those with the following characteristics were excluded from the study.</p><p class="elsevierStylePara">Patients who had used antihypertensive drugs in recent two weeks, those that they didn’t need to ultrafiltration during HD, Patients who had used other preventive measure for prevention of hypotention during HD such as cold dialysate, midodrine and others, those with a history of MI in 6 weeks ago, anemic patients with hemoglobin level less than 10 gr/dl, and Patients who were suffered from gastrointestinal bleeding during HD. The study was explained to the subjects and all participants provided written informed consent. The study has approved by the Research Center of Ahvaz Joundishapur University of Medical Sciences.</p><p class="elsevierStylePara">After selection of patients, in the first month of the study, all participants were received nasal spray of distill water (two puffs) 30 minutes before all HD session (Placebo group, Group 1)) and then after a 30-day washout period we were used intranasal DDAVP (two puffs) 30 minutes before all HD session (Vasopressin group, Group, 2).</p><p class="elsevierStylePara">Blood pressure was measured and recorded by a trained neurse, just before the needles for dialysis access were placed, 2 hour after starting and at the end of each HD session. Mean arterial blood pressure (MABP) was also calculated as the diastolic pressure plus one-third of the pulse pressure. For measurement of blood pressure, the patients were seated for at least 5 minutes and arm supported at heart level. We were used a manual aneroid sphygmomanometer with an appropriate cuff size so that the cuff bladder encircles at least 80% of the arm. An intradialytic hypotensive episode was defined as a fall in systolic blood pressure of at least 10 mm Hg two hour after starting and or after termination of HD compared to pre dialysis.</p><p class="elsevierStylePara">Statistical analysis: For data analysis, we were used the statistical package for social sciences (SPSS) version 15 software. Chi-square tests or Fishers exact test were performed to evaluate the distribution of variables. Statistical significance was assessed at a probability level of < 0.05 in all analysis. </p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Hemodialysis Methods</span></p><p class="elsevierStylePara">Hemodialysis was performed for 9-12 h, three times a week, using Fresenius machines, semi-synthetic (cellulose diacetate), or synthetic (polysulfone) dialyzer membranes, and bicarbonate- buffered dialysate (sodium 135 mmol/l, potassium 2 mmol/l, calcium 1. 5 mmol/l, magnesium 0.5 mmol/l and bicarbonate 35 mmol/l). Blood flow rate was maintained from 250 to 400 mL/min, and the dialysate flow rate at 500 mL/min. Dialysate temperature was 36.58C throughout the study period. Dry weight and rate of ultrafiltration was determined individually by the patient’s attending nephrologist on clinical grounds. </p><p class="elsevierStylePara"><span class="elsevierStyleBold"><br></br></span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">KT/V</span></p><p class="elsevierStylePara">KT/V was also calculated for the first and the end HD session in two groups. For evaluation of KT/V, blood sampling for blood urea nitrogen (BUN) was done immediately before HD session and for postdialysis BUN, our practice was to slow the blood pump to 100 ml/ min and then obtain the blood sample 15 seconds later.<span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara">Results: One hundred twenty eight ESRD patients were on HD in Imam Hospital, Ahvaz, Iran. From them, one hundred eleven patients were not assessable because they had no hypotensive episodes and or because they had other exclusion criteria; therefore the study was performed on seventeen HD patients (nine men, eight women) with mean age of 47.5 years (range of 22 yr to 65 yr). The cause of ESRD in the patients on the study was diabetes mellitus in eight patients (four men and four women) and others were non diabetic (Hypertension, 5; Unknown, 3 and ADPKD, 1). In overall 408 HD performed in the period of the study; 204 times (17 × 12) in the placebo group (Group, 1) and 204 times (17 × 12) in the vasopressin group (Group, 2).</p><p class="elsevierStylePara">The kind of hemodialysis machines, dialyzer membranes, dialysate were the same in the both groups. The mean rate of blood flow rate, dialysate flow rate and ultrafiltration rate among vasopressin and placebo group in each HD session were 300 ml/mim and 290 ml/min, 500ml/min and 500ml/min and 2.3 liters and 2.2 liters respectively without a significant difference between them.</p><p class="elsevierStylePara">Hypotensive episode during HD occurred 18 times (8.82%) in vasopressin group compared with 125 times (61.27%) in placebo group and therefore the rate of IDH was significantly lower in vasopressin group (p=0.001). The mean of systolic and diastolic blood pressure after termination of HD session were 111.854 and 65.228 in vasopressin group and 102.671 and 59.550 in placebo group and there were a significant association between them (p=0.025 in mean of systolic and p= 0.033 in mean of diastolic blood pressure). </p><p class="elsevierStylePara">In addition, the mean of arterial blood pressure after termination of HD session in vasopressin group was 80.77 and in placebo group was 73.92 and also there was a significant difference between them (p=0.0001). The mean of Kt/v in group 1 and 2 were 1.297 ±0.217 and 1.290 ± 0.252 without any association between them (p=0.896).</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara">The pathogenesis of hemodialysis hypo­tension is thought to be multifactorial, but generally results from inadequate cardiovascular compensatory mechanisms and impairs autonomic response to the aggressive reduction of circulating blood volume during ultrafiltration<span class="elsevierStyleSup">15,16</span>. In addition there are very strong arguments for an important role of several vasoactive substances such as adenosine (cardiodepressive and endogenous vasodilator) and nitric oxide (endogenous vasodilator) which may be synthesized or released during dialysis in pathogenesis of IDH<span class="elsevierStyleSup">17,18</span>.</p><p class="elsevierStylePara">Although vasopressin is widely recognized for its role in the regulation of sodium balance and plasma osmolality, it is also a well-recognized vasoconstrictor and the role of vasopressin insufficiency as an important cause of IDH has also demonstrated in recent years by several observations<span class="elsevierStyleSup">19-23</span>. In the first time, the possible role of vasopressin insufficiency as a cause of hemodynamic instability during HD, showed by Friess et al in 1994. They measured plasma AVP level in<span class="elsevierStyleBold"> </span>23 patients with recurrent<span class="elsevierStyleBold"> </span>dialysis<span class="elsevierStyleBold"> </span>hypotension and showed that AVP concentration only increased in six patients with nausea and hypotension and in the remaining 17 patients without nausea AVP level did not increased<span class="elsevierStyleSup">19</span>.</p><p class="elsevierStylePara">In the setting of hypotension as an example in patients with septic shock, the release of vasopressin is usually increased and in together with other vasoconstrictors cause systemic vascular resistance and elevates blood pressure<span class="elsevierStyleSup">23</span>. It is therefore hypothesized that the inappropriately low vasopressin concentrations due to decreased endogenous AVP synthesis and or secretion may explain recurrent<span class="elsevierStyleBold"> </span>dialysis<span class="elsevierStyleBold"> </span>hypotension in the previous study.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic">Sato et al and cignareli et al in two separate study in </span>nondialysis diabetic patients with severe <span class="elsevierStyleItalic">diabetic neuropathy demonstrated that </span>AVP concentrations do not appropriately increase in the setting of orthostatic hypotension<span class="elsevierStyleSup">24,25</span>. Therefore the results of two studies are supported the important effect of vasopressin in maintenance of blood pressure. In addition because of diabetes mellitus is the most common co morbidities associated with ESRD, the results of these studies also suggested that vasopressin insufficiency may be a part of the underlying mechanism of IDH in diabetic patients.</p><p class="elsevierStylePara">Mira Rho et al also demonstrated vasopressin insufficiency as a possible mechanism of IDH in ESRD patients and supported the findings of Friess <span class="elsevierStyleItalic">et al<span class="elsevierStyleSup">20</span>. </span>They performed an observational pilot study on 20 chronic hemodialysis patients and observed that AVP concentration did not increase as would normally be expected in patients with symptomatic IDH in response to severe hypotension and therefore they have suggested that intravenous vasopressin and perhaps intranasal vasopressin administration may improve hemodynamic stability in patients with symptomatic IDH.</p><p class="elsevierStylePara">Although in our study we were not measured concentration of AVP in HD patients with IDH, however the data from this clinical trial are also supported the findings of the studies of Friess et al and Mira Rho et al. According to the our study, the use of two puffs of intranasal DDAVP 30 minutes before HD session was significantly associated with a decreased incidence of hypotensive episodes among patients that they are received ultrafiltration during dialysis.<span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara">Other than our study, there are few clinical trials that they have evaluated the possible effect of vasopressin in prevention of IDH episodes during hemodialysis. As an example, in a study Van der Zee et al measured plasma vasopressin concentration during HD and found that plasma vasopressin levels did not increase during ultrafiltration dialysis. Then they examined 22 ESRD patients in a randomized, double-blinded and placebo-controlled trial and showed that blood pressure was more stable in the patients receiving constant infusion of a non-pressor dose of vasopressin during hemodialysis and the incidence of symptomatic hypotensive episode was significantly lower in comparison to the placebo group. In finally they concluded that administration of vasopressin improves cardiovascular stability and facilitates fluid removal during hemodialysis<span class="elsevierStyleSup">21</span>.</p><p class="elsevierStylePara">Jills et al have also showed efficacy of vasopressin in prevention of hypotension during hemodialysis. In this double-blind crossover study, they were used intranasal lysine vasopressin in 6 patients with refractory hemodialysis-induced hypotension and have reported that Systolic, diastolic, and mean arterial blood pressures were more stable with use of vasopressin<span class="elsevierStyleSup">22</span>. </p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">CONCLUSION</span></p><p class="elsevierStylePara">Intradialytic hypotension (IDH) continues to be a leading problem in patients with ESRD and it has an important negative effect on health-related quality of life. Unfortunately, because of small number of comparative studies, there are no generally accepted guidelines for prevention of this problem. Some studies have showed that AVP concentration do not increase as would normally be expected in patients with symptomatic IDH. Therefore it is hypothesized that the inappropriately low vasopressin concentrations is a significant part of the underlying mechanism of IDH and perhaps intravenous vasopressin and or intranasal vasopressin administration may prevent hypotension during HD. According to the present clinical trial, the use of two puffs of intranasal DDAVP 30 minutes before HD session Compared with placebo is significantly associated with a decreased incidence of intradialytic hypotension episodes among patients that they are received ultrafiltration hemodialysis. Although the results of our study are interesting but the small number of patients enrolled in the study is a limit factor and therefore further research with larger number of patients is needed to determine the effect of vasopressin administration for prevention of hypotension during HD.<span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Acknowledgements</span></p><p class="elsevierStylePara">This paper is issued from thesis of Dr. Mehdi Talebzadeh and financial support was provided by Ahvaz Joundishapur University of Medical Sciences. We would like to express our appreciation to the division head and the staff and of course ESRD patients in HD center of Imam Hospital in the province of Khuzestan, Ahvaz, Iran, for their help.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflict of interest</span></p><p class="elsevierStylePara">The authors declare they have no potential conflicts of interest related to the contents of this article.</p>" "pdfFichero" => "P1-E532-S3377-A10967-EN.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439167" "palabras" => array:1 [ 0 => "Hipotensión intradialítica" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439169" "palabras" => array:1 [ 0 => "Ultrafiltración hemodiálisis" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439171" "palabras" => array:1 [ 0 => "DDAVP" ] ] ] "en" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439168" "palabras" => array:1 [ 0 => "Intradialytic Hypotension" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439170" "palabras" => array:1 [ 0 => "Ultrafiltration hemodialysis" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439172" "palabras" => array:1 [ 0 => "DDAVP" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Introducción:</span><span class="elsevierStyleBold"> </span>La aparición de hipotensión intradialítica durante la hemodiálisis (HD) en la que el objetivo principal es la eliminación de fluidos, contribuye a una morbilidad excesiva que se asocia con la diálisis<span class="elsevierStyleBold">. Materiales y métodos:</span><span class="elsevierStyleBold"> </span>Mediante un ensayo clínico doble ciego, comparamos los posibles efectos de la DDAVP intranasal con los del agua destilada intranasal como placebo en la prevención de la hipotensión intradialítica (HID) en pacientes con HID sintomática diagnosticada. Durante el primer mes del estudio, la pulverización nasal de agua destilada se realizaba 30 minutos antes de todas las sesiones de HD (grupo de placebo, grupo 1) y luego, tras un periodo de reposo de 30 días, utilizamos DDVAP intranasal 30 minutos antes de las sesiones de HD (grupo vasopresina, grupo 2). La presión arterial se medía justo antes de la HD, dos horas después y una vez finalizada la HD. Se definió como episodio de hipotensión la caída de la presión arterial sistólica del más de 10 mmHg. <span class="elsevierStyleBold">Resultados:</span><span class="elsevierStyleBold"> </span>Se incluyó en el estudio un total de 17 pacientes (nueve hombres y ocho mujeres de 47,5 años de edad media) con HID sintomática diagnosticada. En ambos grupos, el tipo de membranas de diálisis, la media del flujo sanguíneo, la tasa del flujo dializado y la tasa de ultrafiltración eran los mismos. Ambos grupos se sometieron a 204 sesiones de HD (17 x 12). Los episodios de hipotensión sucedieron en 18 ocasiones (8,82%) en el grupo de vasopresina en comparación con las 125 ocasiones (61,27%) del grupo de placebo y hubo una relación significativa entre ellos (p=0,0001). Además, la presión arterial media en el grupo de vasopresina era de 80.77 y en el grupo de placebo era de 73,92 e igualmente se observó una asociación significativa (p=0,0001). La media Kt/v en el grupo 1 y el 2 fue de 1,29 y 1,28 sin diferencias entre ellos (p=0,896). <span class="elsevierStyleBold">Conclusión:</span><span class="elsevierStyleBold"> </span>Estos resultados indican que, en comparación con el placebo, la vasopresina está relacionada de forma significativa con una menor incidencia de los episodios de hipotensión intradialítica durante la hemodiálisis.</p>" ] "en" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Introduction:</span> The development of intradialytic hypotension during hemodialysis (HD) in which fluid removal is the primary goal, contributes to the excessive morbidity that is associated with the dialysis procedure. <span class="elsevierStyleBold">Materials and Methods:</span> In a double blinded clinical trial, we compared the possible effect of intranasal DDAVP with intranasal distilled water as a placebo in prevention of intradialytic hypotension (IDH) in patients with known symptomatic IDH. In the first month of the study, nasal spray of distill water were administrated 30 minutes before all HD session (Placebo Group, Group 1) and then after a 30-day washout period we were used intranasal DDAVP 30 minutes before HD session (Vasopressin Group, Group 2). Blood pressure was measured just before HD, two hours later and after termination of HD. A hypotensive episode was defined as a decline of systolic blood pressure of more than 10mm Hg. <span class="elsevierStyleBold">Results:</span> In overall Seventeen patients (nine men, eight women; mean age, 47.5 years) with known symptomatic IDH were enrolled in the study. The kind of dialysis membranes, mean of blood flow rate, dialyzate flow rate and ultrafiltration rate were the same in both groups. Each group has 204 HD session (17 * 12). Hypotensive episode occurred 18 times (8.82%) in vasopressin group compared with 125 times (61.27%) in placebo group and there was a significant association between them (p=0.0001). In addition mean arterial blood pressure in vasopressin group was 80.77 and in placebo group was 73.92 and also there was a significant association (p=0.0001). The mean Kt/v in group 1 and 2 were 1.29 and 1.28 without any differences between them (p=0.896). <span class="elsevierStyleBold">Conclusion:</span> These results indicate that Compared with placebo, Vasopressin is significantly associated with a decreased incidence of intradialytic hypotension episodes during hemodialysis.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:25 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis. Artif Organs 1994;18:880. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7887824" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Van der Sande FM, Kooman JP, Leunissen KM. Intradialytic hypotension--new concepts on an old problem. Nephrol Dial Transplant 2000;15:1746. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11071958" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "3.\u{A0}Milinkovic M, Zidverc-Trajkovic J, Sternic N, Trbojevic-Stankovic J,\u{A0}Maric I,\u{A0}Milic M,\u{A0}et al. Hemodialysis headache. Clin Nephrol 2009;71:158." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D,\u{A0}et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998;4:561-9." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004;66:1212-20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15327420" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Dasselaar JJ, Huisman RM, de Jong PE, Franssen CF. Measurement of relative blood volume changes during haemodialysis: merits and limitations.\u{A0}Nephrol Dial Transplant \u{A0}2005;20(10):2043-9.\u{A0}" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D,\u{A0}et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 2007;22 Suppl 2:ii22-44. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17507425" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers.\u{A0}Kidney Int 2001;59(3):1175-81. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11231376" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "9.\u{A0}Daugirdas JT. Preventing and managing hypotension.\u{A0}Semin Dial\u{A0}1994;7:276-83." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "10.\u{A0}Knoll GA, Grabowski JA, Dervin GF,\u{A0}O'Rourke K. A randomized, controlled trial of albumin versus saline for the treatment of intradialytic hypotension.\u{A0}J Am Soc Nephrol 2004;15(2):487-92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14747397" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "11.\u{A0}Yu AW, Ing TS, Zabaneh RI, Jensen UB, Tryggvason K.\u{A0}Effect of dialysate temperature on central hemodynamics and urea kinetics.\u{A0}Kidney Int 1995;48:327-43." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "12.\u{A0}Prakash S, Garg AX, Heidenheim AP,\u{A0}House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review.\u{A0}Nephrol Dial Transplant 2004;19:2553-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15280522" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "13.\u{A0}Moret K, Aalten J, Wall Bake W,\u{A0}Gerlag P,\u{A0}Beerenhout C,\u{A0}van der Sande F,\u{A0}et al. The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients.\u{A0}Nephrol Dial Transplant 2006;21:138-44.\u{A0} <a href="http://www.ncbi.nlm.nih.gov/pubmed/16144849" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "14.\u{A0}Donauer J. Hemodialysis-induced hypotension: impact of technologic advances.\u{A0}Semin Dial 2004;17:333-5." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Daugirdas JT. Pathophysiology of dialysis hypotension: an update.\u{A0}Am J Kidney Dis 2001;38(4 suppl 4):S11-7." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "16.\u{A0}Leunissen KM, Kooman JP, van Kuijk W, van der Sande F, Luik AJ, van Hooff JP. Preventing haemodynamic instability in patients at risk for intra-dialytic hypotension. Nephrol Dial Transplant 1996;11 Suppl 2:11-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8803987" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "17.\u{A0}Armengol NE CAA, Bono Illa M, Calls Ginesta J, Gaya Bertran J, Rivera Fillat DR. Vasoactive hormones in uraemic patients with chronic hypotension. Nephrol Dial Transplant 1997;12:321-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9132653" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "18.\u{A0}Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004;66:1212-20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15327420" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "19.\u{A0}Friess U, Rascher W, Ritz E, Gross P. Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant 1995;10:1421-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8538936" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "20.\u{A0}\u{A0}Rho M,\u{A0}Perazella MA,\u{A0}Parikh CR,\u{A0}Peixoto AJ,\u{A0}Brewster UC. Serum Vasopressin Response in Patients with Intradialytic Hypotension: A Pilot Study. Clin J Am Soc Nephrol 2008;3(3):729-35. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18256370" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "21.\u{A0}Van der Zee S, Thompson A, Zimmerman R, Lin J, Huan Y, Braskett M, et al. Vasopressin administration facilitates fluid removal during hemodialysis.\u{A0}Kidney Int 2007;71:318-24. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17003815" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "22.\u{A0}Lindberg JS, Copley JB, Melton K, Wade CE, Abrams J, Goode D.\u{A0} Lysine Vasopressin in the Treatment of Refractory Hemodialysis-Induced Hypotension.\u{A0}Am J Nephrol 1990;10:269-75. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2240053" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "23.\u{A0}Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120:989-1002. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11555538" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "24.\u{A0}Sato K, Kimura T, Ota K, Shoji M, Ohta M, Yamamoto T, et al. Changes in plasma vasopressin levels and cardiovascular function due to postural changes in diabetic neuropathy. Tohoku J Exp Med 1995;177:49-60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8693486" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "25.\u{A0}Cignarelli M, De Pergola G, Paternostro A, Corso M, Cospite MR, Centaro GM, et al. Arginine-vasopressin response to supine-erect posture change: an index for evaluation of the integrity of the afferent component of baroregulatory system in diabetic neuropathy. Diabete Metab 1986;12:28-33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3699228" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003200000001/v0_201502091620/X2013251412000503/v0_201502091620/en/main.assets" "Apartado" => array:4 [ "identificador" => "35441" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Originals" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003200000001/v0_201502091620/X2013251412000503/v0_201502091620/en/P1-E532-S3377-A10967-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000503?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 9 | 4 | 13 |
| 2024 October | 71 | 31 | 102 |
| 2024 September | 75 | 22 | 97 |
| 2024 August | 81 | 58 | 139 |
| 2024 July | 55 | 24 | 79 |
| 2024 June | 114 | 54 | 168 |
| 2024 May | 87 | 46 | 133 |
| 2024 April | 87 | 29 | 116 |
| 2024 March | 53 | 18 | 71 |
| 2024 February | 59 | 41 | 100 |
| 2024 January | 51 | 29 | 80 |
| 2023 December | 45 | 37 | 82 |
| 2023 November | 52 | 39 | 91 |
| 2023 October | 92 | 37 | 129 |
| 2023 September | 41 | 31 | 72 |
| 2023 August | 46 | 25 | 71 |
| 2023 July | 48 | 49 | 97 |
| 2023 June | 70 | 21 | 91 |
| 2023 May | 48 | 32 | 80 |
| 2023 April | 28 | 20 | 48 |
| 2023 March | 37 | 20 | 57 |
| 2023 February | 39 | 12 | 51 |
| 2023 January | 34 | 30 | 64 |
| 2022 December | 48 | 43 | 91 |
| 2022 November | 58 | 36 | 94 |
| 2022 October | 49 | 44 | 93 |
| 2022 September | 41 | 34 | 75 |
| 2022 August | 43 | 48 | 91 |
| 2022 July | 34 | 52 | 86 |
| 2022 June | 40 | 47 | 87 |
| 2022 May | 36 | 22 | 58 |
| 2022 April | 53 | 40 | 93 |
| 2022 March | 79 | 54 | 133 |
| 2022 February | 34 | 44 | 78 |
| 2022 January | 49 | 32 | 81 |
| 2021 December | 57 | 40 | 97 |
| 2021 November | 33 | 40 | 73 |
| 2021 October | 35 | 40 | 75 |
| 2021 September | 41 | 49 | 90 |
| 2021 August | 24 | 33 | 57 |
| 2021 July | 51 | 27 | 78 |
| 2021 June | 25 | 32 | 57 |
| 2021 May | 37 | 30 | 67 |
| 2021 April | 51 | 55 | 106 |
| 2021 March | 34 | 47 | 81 |
| 2021 February | 37 | 15 | 52 |
| 2021 January | 37 | 17 | 54 |
| 2020 December | 24 | 13 | 37 |
| 2020 November | 23 | 19 | 42 |
| 2020 October | 18 | 13 | 31 |
| 2020 September | 26 | 8 | 34 |
| 2020 August | 30 | 13 | 43 |
| 2020 July | 34 | 13 | 47 |
| 2020 June | 30 | 13 | 43 |
| 2020 May | 38 | 11 | 49 |
| 2020 April | 27 | 14 | 41 |
| 2020 March | 28 | 16 | 44 |
| 2020 February | 30 | 19 | 49 |
| 2020 January | 42 | 21 | 63 |
| 2019 December | 35 | 21 | 56 |
| 2019 November | 43 | 26 | 69 |
| 2019 October | 22 | 7 | 29 |
| 2019 September | 52 | 23 | 75 |
| 2019 August | 29 | 15 | 44 |
| 2019 July | 24 | 19 | 43 |
| 2019 June | 56 | 19 | 75 |
| 2019 May | 17 | 17 | 34 |
| 2019 April | 65 | 32 | 97 |
| 2019 March | 58 | 28 | 86 |
| 2019 February | 31 | 14 | 45 |
| 2019 January | 21 | 28 | 49 |
| 2018 December | 94 | 48 | 142 |
| 2018 November | 91 | 20 | 111 |
| 2018 October | 84 | 25 | 109 |
| 2018 September | 66 | 18 | 84 |
| 2018 August | 74 | 26 | 100 |
| 2018 July | 60 | 16 | 76 |
| 2018 June | 49 | 18 | 67 |
| 2018 May | 57 | 17 | 74 |
| 2018 April | 64 | 10 | 74 |
| 2018 March | 56 | 17 | 73 |
| 2018 February | 56 | 10 | 66 |
| 2018 January | 49 | 8 | 57 |
| 2017 December | 70 | 13 | 83 |
| 2017 November | 58 | 19 | 77 |
| 2017 October | 55 | 7 | 62 |
| 2017 September | 53 | 15 | 68 |
| 2017 August | 54 | 6 | 60 |
| 2017 July | 39 | 16 | 55 |
| 2017 June | 54 | 8 | 62 |
| 2017 May | 64 | 13 | 77 |
| 2017 April | 58 | 11 | 69 |
| 2017 March | 57 | 22 | 79 |
| 2017 February | 47 | 9 | 56 |
| 2017 January | 37 | 16 | 53 |
| 2016 December | 94 | 6 | 100 |
| 2016 November | 89 | 14 | 103 |
| 2016 October | 132 | 10 | 142 |
| 2016 September | 145 | 7 | 152 |
| 2016 August | 214 | 9 | 223 |
| 2016 July | 183 | 11 | 194 |
| 2016 June | 146 | 0 | 146 |
| 2016 May | 160 | 0 | 160 |
| 2016 April | 99 | 0 | 99 |
| 2016 March | 96 | 0 | 96 |
| 2016 February | 93 | 0 | 93 |
| 2016 January | 109 | 0 | 109 |
| 2015 December | 128 | 0 | 128 |
| 2015 November | 90 | 0 | 90 |
| 2015 October | 97 | 0 | 97 |
| 2015 September | 81 | 0 | 81 |
| 2015 August | 58 | 0 | 58 |
| 2015 July | 76 | 0 | 76 |
| 2015 June | 39 | 0 | 39 |
| 2015 May | 69 | 0 | 69 |
| 2015 April | 5 | 0 | 5 |
Show all
